Plot of Kaplan–Meier estimator on the length of use of the two most common first-line glaucoma monotherapy drug classes and the five most common drug types during the follow-up between 1995 and 2019 in the FinHealth 2017 Survey sample representing the Finnish adult population aged 30 years or older.
<p>Participants without switch to second-line therapy during the follow-up were considered right-censored with their endpoints shown as vertical lines. After 5 years of follow-up there was a significant difference in the length of use between prostaglandin analogues and beta-blockers according...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| الملخص: | <p>Participants without switch to second-line therapy during the follow-up were considered right-censored with their endpoints shown as vertical lines. After 5 years of follow-up there was a significant difference in the length of use between prostaglandin analogues and beta-blockers according to the log-rank test (p = 0.02), and after 7 years the difference was significant also according to the Gehan–Wilcoxon test (p = 0.02).</p> |
|---|